Top 5 Performing Stocks To Invest In Right Now


What’s the first rule of successful real estate investing? Of course, you just said to yourself, “location, location, location.”

Well, when it comes successful equity trading, the first rule that should come to your mind is “price, price, price.”

More specifically, it is the share price performance of a stock or ETF relative to other stocks and ETFs. In fact, it’s the most important metric to put in your favor.

Let’s say you are looking at a security that is outperforming others in the broad market or within its specific industry group. This should tell you that others on Wall Street think there is something special that makes it worth buying. It’s that simple…

This “something special” could be a variety of things. It could include a proven track record of strong revenue and earnings growth (think: Walt Disney), a breakout product or game-changing service (Netflix), or a high-demand personal technology product (Apple).

Top 5 Performing Stocks To Invest In Right Now: Dynavax Technologies Corporation(DVAX)


Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The company’s lead product candidate includes HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide protection with fewer doses than current licensed vaccines. It also develops Universal Flu vaccine, a Phase 1b clinical trial vaccine for influenza prevention; SD-101, a Phase Ib clinical trial hepatitis C therapy; DV-601, a Phase Ib clinical trial hepatitis B therapy; AZD1419, a preclinical asthma therapy; and DV1179, a Phase 1 trial autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize DV1179 and other endosomal toll-like receptor inhibitors for diseases, such as lupus, psoriasis, and rheumatoid arthritis; and develop a TLR8 inhibitor for the treatment of multiple autoimmune and i nflammatory diseases, as well as has research and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was founded in 1996 and is based in Berkeley, California.


Advisors’ Opinion:

  • [By George Budwell]

    Shares of Dynavax Technologies (NASDAQ:DVAX), a vaccine and immuno-oncology specialist, dropped by 15.9% last month, according to data from S&P Global Market Intelligence. What sparked this sell-off?

  • [By Logan Wallace]

    Dynavax Technologies Co. (NASDAQ:DVAX)’s share price traded down 6% on Wednesday . The stock traded as low as $8.60 and last traded at $8.56. 1,747,224 shares were traded during trading, an increase of 61% from the average session volume of 1,088,373 shares. The stock had previously closed at $9.11.

  • [By Motley Fool Transcription]

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2018 Earnings Conference Call February 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By George Budwell]

    After a rather tumultuous 2018 campaign, shares of Dynavax Technologies (NASDAQ:DVAX) regained their footing last month by gaining a noteworthy 20.4%, according to data from S&P Global Market Intelligence. The catalyst?

Top 5 Performing Stocks To Invest In Right Now: Helmerich & Payne, Inc.(HP)


Helmerich & Payne, Inc. engages in the contract drilling of oil and gas wells. It provides drilling rigs, equipment, personnel, and camps on a contract basis to explore for and develop oil and gas from onshore areas and from fixed platforms, tension-leg platforms, and spars in offshore areas. The company operates through three segments: U.S. Land, Offshore, and International Land. The U.S. Land segment drills primarily in Oklahoma, California, Texas, Wyoming, Colorado, Louisiana, Mississippi, Pennsylvania, Ohio, Utah, New Mexico, Montana, North Dakota, West Virginia, and Nevada. The Offshore segment has drilling operations in the Gulf of Mexico and Equatorial Guinea. The International Land segment conducts drilling operations in Ecuador, Colombia, Argentina, Bahrain, the United Arab Emirates, and Mozambique. As of November 12, 2015, the company operated a fleet of 344 land rigs in the United States; 38 international land rigs; and 9 offshore platform rigs. The company also owns, develops, and operates commercial real estate properties; and researches and develops rotary steerable technology. Its real estate investments include a shopping center comprising approximately 441,000 leasable square feet; multi-tenant industrial warehouse properties covering approximately one million leasable square feet; and approximately 210 acres of undeveloped real estate located in Tulsa, Oklahoma. Helmerich & Payne, Inc. was founded in 1920 and is headquartered in Tulsa, Oklahoma.


Advisors’ Opinion:

  • [By Money Morning News Team]

    Rounding out the top five is a financial services stock, Wheeler Real Estate Investment Trust Inc. (NASDAQ: WHLR), which advanced more than 63% to end the week at $1.80 per share.

  • [By Money Morning Staff Reports]

    Here are last week’s top-performing penny stocks:

    Penny Stock Sector Current Share Price Last Week’s Gain
    OncoCyte Corp. (NYSE: OCX) Healthcare $4.98 159.38%
    Fortress Biotech (NASDAQ: FBIO) Healthcare $2.47 133.02%
    Trevena Inc. (NASDAQ: TRVN) Healthcare $1.01 86.69%
    Celldex Therapeutics Inc. (NASDAQ: CLDX) Healthcare $0.58 66.82%
    Wheeler Real Estate Investment Trust Inc.(NASDAQ: WHLR) Financial $1.80 63.64%
    Scynexis Inc. (NASDAQ: SCYX) Healthcare $1.13 53.64%
    Eldorado Gold Corp. (NYSE: EGO) Basic Materials $3.98 47.96%
    Novus Therapeutics Inc. (NASDAQ: NVUS) Healthcare $4.15 43.60%
    PHI Inc. (NASDAQ: PHII) Services $4.50 42.14%
    BioTime Inc. (NYSE: BTX) Healthcare $1.33 41.50%

    See Now: Our founder just released his No. 1 pick for 2019. Don’t miss this. See urgent briefing here…

  • [By Ethan Ryder]

    Wheeler Real Estate Investment Trust (NASDAQ:WHLR) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Leave a Reply

Your email address will not be published.